SEARCH

SEARCH BY CITATION

References

  • Acharya, S.S., Coughlin, A., DiMichele, D.M. & North American Rare Bleeding Disorder Study Group. (2004) Rare bleeding disorder registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. Journal of Thrombosis and Haemostasis, 2, 248256.
  • Al-Mondhiry, H. & Galanakis, D. (1987) Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis. Journal of Laboratory and Clinical Medicine, 110, 726733.
  • Chung, D.W., Harris, J.E. & Davie, E.W. (1990) Nucleotide sequences of the three fibrinogen genes coding for human fibrinogen. In: Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis (ed. by C.Y.Liu & S.Chien), pp. 3948. Plenum Press, New York.
  • Collen, D. & Lijnen, H.R. (2004) Tissue-type plasminogen activator: a historical perspective and personal account. Journal of Thrombosis and Haemostasis, 2, 541546.
  • Collet, J.P., Soria, J., Mirshahi, M., Hirsch, M., Dagonnet, F.B., Caen, J. & Soria, C. (1993) Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure. Blood, 82, 24622469.
  • Collet, J.P., Park, D., Lesty, C., Soria, J., Soria, C., Montalescot, G. & Weisel, J.W. (2000) Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 13541361.
  • Côté, H.C., Lord, S.T., & Pratt, K.P. (1998) γ-chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the γ chain of human fibrinogen. Blood, 92, 21952212.
  • Doolittle, R.F. (2003) X-ray crystallographic studies on fibrinogen and fibrin. Journal of Thrombosis and Haemostasis, 1, 15591565.
  • Everse, S.J., Spraggon, G. & Doolittle, R.F. (1998) A three-dimensional consideration of variant human fibrinogens. Thrombosis and Haemostasis, 80, 19.
  • Falls, L.A. & Farrell, D.H. (1997) Resistance of γA/γ′ fibrin clots to fibrinolysis. Journal of Biological Chemistry, 272, 1425114256.
  • Gabriel, D.A., Muga, K. & Boothroyd, E.M. (1992) The effect of fibrin structure on fibrinolysis. Journal of Biological Chemistry, 267, 2425924263.
  • Galanakis, D.K., Lane, B.P. & Simon, S.R. (1987) Albumin modulates lateral assembly of fibrin polymers: evidence of enhanced fine fibril formation and of unique synergism with fibrinogen. Biochemistry, 26, 23892400.
  • Galanakis, D.K., Henschen, A., Peerschke, E.I. & Kehl, M. (1989) Fibrinogen Stony Brook, a heterozygous Aα16Arg[RIGHTWARDS ARROW]Cys dysfibrinogenemia. Journal of Clinical Investigation, 84, 295304.
  • Galanakis, D.K., Henschen, A., Schuback, W., Lord, S. & Al-Mondhiry, H. (1990) Two abnormal Aα16Arg[RIGHTWARDS ARROW]Cys dysfibrinogens, Hershey II and Leogan: determination of abnormal structure and heterozygosity by amplification of genomic DNA using the polymerase chain reaction and by amino acid sequence analyses. In: Fibrinogen-Current Basic and Clinical Aspects (ed. by M.Matsuda, S.Iwanaga & A.Takada), pp. 173178. Elsevier Science, Kyoto, Japan.
  • Guthold, M., Liu, W., Stephens, B., Lord, S.T., Hantgan, R.R., Erie, D.A., Taylor, Jr, R.M. & Superfine, R. (2004) Visualization and mechanical manipulations of individual fibrin fibers suggest that fiber cross section has fractal dimension 1·3. Biophysical Journal, 87, 42264236.
  • Hanss, M. & Biot, F. (2001) A database for human fibrinogen variants. Annals of the New York Academy of Sciences, 936, 8990 Available at: http://www.geht.org/databaseang/fibrinogen [last accessed 5 May 2006].
  • Haverkate, F. & Samama, M. (1995) Familial dysfibrinogenemia and thrombophilia. Thrombosis and Haemostasis, 73, 151161.
  • Henschen, A., Kehl, M., Southan, C., Lottspeich, F. & Georgopoulos, D. (1983) Genetically abnormal fibrinogens-some current characterisation strategies. In: Fibrinogen: Structure, Functional Aspects, Metabolism, Vol. 2 (ed. by F.Haverkate, A.Henschen, W.Nieuwenhuizen & P.W.Straub), pp. 125144. Walter de Gruyter & Co., Berlin.
  • Kazal, L.A., Amsel, S., Miller, O.P. & Tocantins, L.M. (1963) The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proceedings of the Society for Experimental Biology and Medicine, 113, 989994.
  • Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680685.
  • Lee, M.H., Kaczmarek, E., Chin, D.T., Oda, A., McIntosh, S., Bauer, K.A., Clyne, L.P. & McDonagh, J. (1991) Fibrinogen Ledyard (Aα Arg16[RIGHTWARDS ARROW]Cys): biochemical and physiologic characterization. Blood, 78, 174417452.
  • Lorand, L. (2005) Factor XIII and the clotting of fibrinogen: from basic research to medicine. Journal of Thrombosis and Haemostasis, 3, 13371348.
  • Matsuda, M., Sugo, T., Yoshida, N., Terukina, S., Yamazumi, K., Niwa, K. & Maekawa, H. (1999) Structure and function of fibrinogen: insights from dysfibrinogens. Thrombosis and Haemostasis, 82, 283290.
  • Medved, L. & Nieuwenhuizen, W. (2003) Molecular mechanisms of initiation of fibrinolysis by fibrin. Thrombosis and Haemostasis, 89, 409419.
  • Miyata, T., Terukina, S., Matsuda, M., Kasamatsu, A., Takeda, Y., Murakami, T. & Iwanaga, S. (1987) Fibrinogens Kawaguchi and Osaka: an amino acid substitution of Aα arginine-16 to cysteine which forms an extra interchain disulfide bridge between the two Aα chains. Journal of Biochemistry (Tokyo), 102, 93101.
  • Moaddel, M., Falls, L.A. & Farrell, D.H. (2000) The role of γA/γ’ fibrinogen in plasma factor XIII activation. Journal of Biological Chemistry, 275, 3213532140.
  • Mosesson, M. (1999) Dysfibrinogenemia and thrombosis. Seminars in Thrombosis and Hemostasis, 25, 311319.
  • Sakata, Y. & Aoki, N. (1980) Cross-linking of α2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. Journal of Clinical Investigation, 65, 290297.
  • Soria, J., Soria, C., Samama, M., Henschen, A. & Southan, C. (1982) Detection of fibrinogen abnormality in dysfibrinogenemia: special report on fibrinogen Metz characterized by an amino acid substitution located at the peptide bond cleaved by thrombin. In: Fibrinogen: Recent Biochemical and Medical Aspects (ed. by A.Henschen, H.Graeff & F.Lottspeich), pp. 129143. Walter de Gruyter & Co., Berlin.
  • Southan, C., Lane, D.A. & Henschen, A. (1983) Functional characterisation and protein chemical analysis of two new cases of dysfibrinogenemia, London III and IV. In: Fibrinogen: Structure, Functional Aspects, Metabolism, Vol. 2 (ed. by F.Haverkate, A.Henschen, W.Nieuwenhuizen & P.W.Straub), pp. 167182. Walter de Gruyter & Co., Berlin.
  • Stucki, B., Zenhäusern, R., Biedermann, B., Baudo, F., Redaelli, R., Lämmle, B. & Furlan, M. (1999) Fibrinogens Bern IV, Bern V, and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aα chain. Blood Coagulation & Fibrinolysis, 10, 9399.
  • Torbet, J. (1986) Fibrin assembly in human plasma and fibrinogen/albumin mixtures. Biochemistry, 25, 53095314.
  • Weisel, J.W. (2005) Fibrinogen and fibrin. Advances in Protein Chemistry, 70, 247299.